The study focuses on older adults who are both frail and have low iron levels together with cardiovascular disease. Frailty means reduced strength and stamina, while iron deficiency can cause tiredness and weakness. The trial compares three options: an infusion of the iron drug ferric carboxymaltose given through a vein, a daily oral tablet of ferrous sulphate, and a matching placebo. The main goal is to see whether adding iron improves physical ability, overall well‑being, and thinking skills over a year.
Participants are randomly assigned to one of the three groups and receive their assigned treatment for 12 months. At the start and at the end of the study, simple tests measure how well they can walk, stand, and balance, and questionnaires ask about daily life and health. Throughout the year, any falls or hospital stays are recorded, and regular check‑ins ensure safety and collect the needed information.



Poland